DB

Dakshaben Bharatkumar Patel

Active Director Director DIN 06817077
DIN 06817077 First appointment Mar 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Dakshaben Bharatkumar Patel

Data last updated:

Dakshaben Bharatkumar Patel is a Director at Staphy Pharma Limited (since 2014). The company operates in Pharma.

DIN 06817077
Primary Designation Director
Industry Pharma
First Appointment 04 Mar 2014
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Staphy Pharma Limited U51909GJ2014PLC078966
Director04 Mar 20142014Active

Board colleagues of Dakshaben Bharatkumar Patel

Directorship timeline

Open interactive timeline →
Staphy Pharma Limited
Premium access

Shareholding and investment profile for Dakshaben Bharatkumar Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dakshaben Bharatkumar Patel

Dakshaben Bharatkumar Patel currently holds 1 directorship: Staphy Pharma Limited (Director, since 04 Mar 2014).

Dakshaben Bharatkumar Patel was first appointed on 04 Mar 2014 as Director at Staphy Pharma Limited.

The current boards of Dakshaben Bharatkumar Patel's companies include Becharlal Vishram Dadga (Staphy Pharma Limited), Bharatkumar Becharlal Patel (Staphy Pharma Limited), Kantilal Hansraj Patel (Staphy Pharma Limited), Kruti Vijay Nayani (Staphy Pharma Limited), Vijaykumar Kantilal Nayani (Staphy Pharma Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available